{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:47:57Z","timestamp":1791114477400,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"50","license":[{"start":{"date-parts":[[2010,9,6]],"date-time":"2010-09-06T00:00:00Z","timestamp":1283731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,9,6]],"date-time":"2010-09-06T00:00:00Z","timestamp":1283731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2010,12,16]]},"DOI":"10.1038\/onc.2010.393","type":"journal-article","created":{"date-parts":[[2010,9,6]],"date-time":"2010-09-06T06:23:39Z","timestamp":1283754219000},"page":"6543-6556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Rheb activates AMPK and reduces p27Kip1 levels in Tsc2-null cells via mTORC1-independent mechanisms: implications for cell proliferation and tumorigenesis"],"prefix":"10.1038","volume":"29","author":[{"given":"M D","family":"Lacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Pincheira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Camoretti-Mercado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Matli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R S","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A F","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,6]]},"reference":[{"key":"BFonc2010393_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/bcr722","volume":"6","author":"A Alkarain","year":"2004","unstructured":"Alkarain A, Slingerland J . (2004). Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer. Breast Cancer Res 6: 13\u201321.","journal-title":"Breast Cancer Res"},{"key":"BFonc2010393_CR2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S1534-5807(04)00103-0","volume":"6","author":"RK Assoian","year":"2004","unstructured":"Assoian RK . (2004). Stopping and going with p27kip1. Dev Cell 6: 458\u2013459.","journal-title":"Dev Cell"},{"key":"BFonc2010393_CR3","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","volume":"97","author":"T Carsillo","year":"2000","unstructured":"Carsillo T, Astrinidis A, Henske EP . (2000). Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci USA 97: 6085\u20136090.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2010393_CR4","doi-asserted-by":"publisher","first-page":"32493","DOI":"10.1074\/jbc.C300226200","volume":"278","author":"AF Castro","year":"2003","unstructured":"Castro AF, Rebhun JF, Clark GG, Quilliam LA . (2003). Rheb binds TSC2 and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. J Biol Chem 278: 32493\u201332496.","journal-title":"J Biol Chem"},{"key":"BFonc2010393_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s004390000348","volume":"107","author":"JP Cheadle","year":"2000","unstructured":"Cheadle JP, Reeve MP, Sampson JR, Kwiatkowski DJ . (2000). Molecular genetic advances in tuberous sclerosis. Hum Genet 107: 97\u2013114.","journal-title":"Hum Genet"},{"key":"BFonc2010393_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2006.01.021","volume":"9","author":"AY Choo","year":"2006","unstructured":"Choo AY, Blenis J . (2006). TORgeting oncogene addiction for cancer therapy. Cancer Cell 9: 77\u201379.","journal-title":"Cancer Cell"},{"key":"BFonc2010393_CR7","doi-asserted-by":"publisher","first-page":"17414","DOI":"10.1073\/pnas.0809136105","volume":"105","author":"AY Choo","year":"2008","unstructured":"Choo AY, Yoon SO, Kim SG, Roux PP, Blenis J . (2008). Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc Natl Acad Sci USA 105: 17414\u201317419.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2010393_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1086\/316951","volume":"68","author":"SL Dabora","year":"2001","unstructured":"Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J et al. (2001). Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 68: 64\u201380.","journal-title":"Am J Hum Genet"},{"key":"BFonc2010393_CR9","doi-asserted-by":"publisher","first-page":"6436","DOI":"10.1038\/sj.onc.1209886","volume":"25","author":"JB Easton","year":"2006","unstructured":"Easton JB, Houghton PJ . (2006). mTOR and cancer therapy. Oncogene 25: 6436\u20136446.","journal-title":"Oncogene"},{"key":"BFonc2010393_CR10","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S0140-6736(03)13044-9","volume":"361","author":"N El-Hashemite","year":"2003","unstructured":"El-Hashemite N, Zhang H, Henske EP, Kwiatkowski DJ . (2003). Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet 361: 1348\u20131349.","journal-title":"Lancet"},{"key":"BFonc2010393_CR11","doi-asserted-by":"publisher","first-page":"9878","DOI":"10.1158\/0008-5472.CAN-07-1394","volume":"67","author":"GA Finlay","year":"2007","unstructured":"Finlay GA, Malhowski AJ, Liu Y, Fanburg BL, Kwiatkowski DJ, Toksoz D . (2007). Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR\/S6 kinase activity. Cancer Res 67: 9878\u20139886.","journal-title":"Cancer Res"},{"key":"BFonc2010393_CR12","doi-asserted-by":"publisher","first-page":"28706","DOI":"10.1074\/jbc.M203668200","volume":"277","author":"N Fujita","year":"2002","unstructured":"Fujita N, Sato S, Katayama K, Tsuruo T . (2002). Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization. J Biol Chem 277: 28706\u201328713.","journal-title":"J Biol Chem"},{"key":"BFonc2010393_CR13","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S1097-2765(03)00220-X","volume":"11","author":"A Garami","year":"2003","unstructured":"Garami A, Zwartkruis FJ, Nobukuni T, Joaquin M, Roccio M, Stocker H et al. (2003). Insulin activation of Rheb, a mediator of mTOR\/S6K\/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 11: 1457\u20131466.","journal-title":"Mol Cell"},{"key":"BFonc2010393_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1042\/BJ20081668","volume":"416","author":"JM Garcia-Martinez","year":"2008","unstructured":"Garcia-Martinez JM, Alessi DR . (2008). mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J 416: 375\u2013385.","journal-title":"Biochem J"},{"key":"BFonc2010393_CR15","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1158\/1535-7163.MCT-04-0347","volume":"4","author":"CL Gau","year":"2005","unstructured":"Gau CL, Kato-Stankiewicz J, Jiang C, Miyamoto S, Guo L, Tamanoi F . (2005). Farnesyltransferase inhibitors reverse altered growth and distribution of actin filaments in Tsc-deficient cells via inhibition of both rapamycin-sensitive and -insensitive pathways. Mol Cancer Ther 4: 918\u2013926.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2010393_CR16","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1101\/gad.889901","volume":"15","author":"K Gottlob","year":"2001","unstructured":"Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N . (2001). Inhibition of early apoptotic events by Akt\/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 15: 1406\u20131418.","journal-title":"Genes Dev"},{"key":"BFonc2010393_CR17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"DM Gwinn","year":"2008","unstructured":"Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS et al. (2008). AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30: 214\u2013226.","journal-title":"Mol Cell"},{"key":"BFonc2010393_CR18","doi-asserted-by":"publisher","first-page":"32081","DOI":"10.1074\/jbc.M502876200","volume":"280","author":"A Hahn-Windgassen","year":"2005","unstructured":"Hahn-Windgassen A, Nogueira V, Chen CC, Skeen JE, Sonenberg N, Hay N . (2005). Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J Biol Chem 280: 32081\u201332089.","journal-title":"J Biol Chem"},{"key":"BFonc2010393_CR19","first-page":"L197","volume":"276","author":"AJ Halayko","year":"1999","unstructured":"Halayko AJ, Camoretti-Mercado B, Forsythe SM, Vieira JE, Mitchell RW, Wylam ME et al. (1999). Divergent differentiation paths in airway smooth muscle culture: induction of functionally contractile myocytes. Am J Physiol 276: L197\u2013206.","journal-title":"Am J Physiol"},{"key":"BFonc2010393_CR20","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.molcel.2008.04.027","volume":"30","author":"F Hong","year":"2008","unstructured":"Hong F, Larrea MD, Doughty C, Kwiatkowski DJ, Squillace R, Slingerland JM . (2008). mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation. Mol Cell 30: 701\u2013711.","journal-title":"Mol Cell"},{"key":"BFonc2010393_CR21","first-page":"1568","volume":"146","author":"SR Howe","year":"1995","unstructured":"Howe SR, Gottardis MM, Everitt JI, Goldsworthy TL, Wolf DC, Walker C . (1995). Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines. Am J Pathol 146: 1568\u20131579.","journal-title":"Am J Pathol"},{"key":"BFonc2010393_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/BJ20080281","volume":"412","author":"J Huang","year":"2008","unstructured":"Huang J, Manning BD . (2008). The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 412: 179\u2013190.","journal-title":"Biochem J"},{"key":"BFonc2010393_CR23","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.1158\/0008-5472.CAN-09-0975","volume":"69","author":"J Huang","year":"2009","unstructured":"Huang J, Wu S, Wu CL, Manning BD . (2009). Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors. Cancer Res 69: 6107\u20136114.","journal-title":"Cancer Res"},{"key":"BFonc2010393_CR24","doi-asserted-by":"publisher","first-page":"R94","DOI":"10.1093\/hmg\/ddp032","volume":"18","author":"K Inoki","year":"2009","unstructured":"Inoki K, Guan KL . (2009). Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment. Hum Mol Genet 18: R94\u2013100.","journal-title":"Hum Mol Genet"},{"key":"BFonc2010393_CR25","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1101\/gad.1110003","volume":"17","author":"K Inoki","year":"2003","unstructured":"Inoki K, Li Y, Xu T, Guan KL . (2003a). Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 17: 1829\u20131834.","journal-title":"Genes Dev"},{"key":"BFonc2010393_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","volume":"115","author":"K Inoki","year":"2003","unstructured":"Inoki K, Zhu T, Guan KL . (2003b). TSC2 mediates cellular energy response to control cell growth and survival. Cell 115: 577\u2013590.","journal-title":"Cell"},{"key":"BFonc2010393_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1158\/1078-0432.CCR-08-0170","volume":"15","author":"J Kim","year":"2009","unstructured":"Kim J, Jonasch E, Alexander A, Short JD, Cai S, Wen S et al. (2009). Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma. Clin Cancer Res 15: 81\u201390.","journal-title":"Clin Cancer Res"},{"key":"BFonc2010393_CR28","doi-asserted-by":"publisher","first-page":"39422","DOI":"10.1074\/jbc.M305371200","volume":"278","author":"S Kovacic","year":"2003","unstructured":"Kovacic S, Soltys CL, Barr AJ, Shiojima I, Walsh K, Dyck JR . (2003). Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J Biol Chem 278: 39422\u201339427.","journal-title":"J Biol Chem"},{"key":"BFonc2010393_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/ncb1537","volume":"9","author":"J Liang","year":"2007","unstructured":"Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M et al. (2007). The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 9: 218\u2013224.","journal-title":"Nat Cell Biol"},{"key":"BFonc2010393_CR30","doi-asserted-by":"publisher","first-page":"7106","DOI":"10.1158\/0008-5472.CAN-06-4798","volume":"67","author":"L Ma","year":"2007","unstructured":"Ma L, Teruya-Feldstein J, Bonner P, Bernardi R, Franz DN, Witte D et al. (2007). Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer. Cancer Res 67: 7106\u20137112.","journal-title":"Cancer Res"},{"key":"BFonc2010393_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1083\/jcb.200408161","volume":"167","author":"BD Manning","year":"2004","unstructured":"Manning BD . (2004). Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J Cell Biol 167: 399\u2013403.","journal-title":"J Cell Biol"},{"key":"BFonc2010393_CR32","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1158\/1535-7163.MCT-08-0631","volume":"8","author":"HU Park","year":"2009","unstructured":"Park HU, Suy S, Danner M, Dailey V, Zhang Y, Li H et al. (2009). AMP-activated protein kinase promotes human prostate cancer cell growth and survival. Mol Cancer Ther 8: 733\u2013741.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2010393_CR33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1056\/NEJMe0707153","volume":"358","author":"E Paul","year":"2008","unstructured":"Paul E, Thiele E . (2008). Efficacy of sirolimus in treating tuberous sclerosis and lymphangioleiomyomatosis. N Engl J Med 358: 190\u2013192.","journal-title":"N Engl J Med"},{"key":"BFonc2010393_CR34","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1128\/MCB.17.7.4059","volume":"17","author":"MD Planas-Silva","year":"1997","unstructured":"Planas-Silva MD, Weinberg RA . (1997). Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. Mol Cell Biol 17: 4059\u20134069.","journal-title":"Mol Cell Biol"},{"key":"BFonc2010393_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1476-4598-8-38","volume":"8","author":"K Pollizzi","year":"2009","unstructured":"Pollizzi K, Malinowska-Kolodziej I, Stumm M, Lane H, Kwiatkowski D . (2009). Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis. Mol Cancer 8: 38.","journal-title":"Mol Cancer"},{"key":"BFonc2010393_CR36","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/hmg\/ddm103","volume":"16","author":"M Rosner","year":"2007","unstructured":"Rosner M, Freilinger A, Hanneder M, Fujita N, Lubec G, Tsuruo T et al. (2007). p27Kip1 localization depends on the tumor suppressor protein tuberin. Hum Mol Genet 16: 1541\u20131556.","journal-title":"Hum Mol Genet"},{"key":"BFonc2010393_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mrrev.2006.03.001","volume":"613","author":"M Rosner","year":"2006","unstructured":"Rosner M, Freilinger A, Hengstschlager M . (2006). The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27. Mutat Res 613: 10\u201316.","journal-title":"Mutat Res"},{"key":"BFonc2010393_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","volume":"22","author":"DD Sarbassov","year":"2006","unstructured":"Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF et al. (2006). Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB. Mol Cell 22: 159\u2013168.","journal-title":"Mol Cell"},{"key":"BFonc2010393_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10038-002-8651-8","volume":"47","author":"T Sato","year":"2002","unstructured":"Sato T, Seyama K, Fujii H, Maruyama H, Setoguchi Y, Iwakami S et al. (2002). Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis. J Hum Genet 47: 20\u201328.","journal-title":"J Hum Genet"},{"key":"BFonc2010393_CR40","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nature04869","volume":"441","author":"RJ Shaw","year":"2006","unstructured":"Shaw RJ, Cantley LC . (2006). Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441: 424\u2013430.","journal-title":"Nature"},{"key":"BFonc2010393_CR41","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/mc.20613","volume":"49","author":"JD Short","year":"2010","unstructured":"Short JD, Dere R, Houston KD, Cai SL, Kim J, Bergeron JM et al. (2010). AMPK-mediated phosphorylation of murine p27 at T197 promotes binding of 14-3-3 proteins and increases p27 stability. Mol Carcinog 49: 429\u2013439.","journal-title":"Mol Carcinog"},{"key":"BFonc2010393_CR42","doi-asserted-by":"publisher","first-page":"6496","DOI":"10.1158\/0008-5472.CAN-07-5756","volume":"68","author":"JD Short","year":"2008","unstructured":"Short JD, Houston KD, Dere R, Cai SL, Kim J, Johnson CL et al. (2008). AMP-activated protein kinase signaling results in cytoplasmic sequestration of p27. Cancer Res 68: 6496\u20136506.","journal-title":"Cancer Res"},{"key":"BFonc2010393_CR43","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","volume":"13","author":"AR Tee","year":"2003","unstructured":"Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J . (2003). Tuberous sclerosis complex gene products, tuberin and hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 13: 1259\u20131268.","journal-title":"Curr Biol"},{"key":"BFonc2010393_CR44","doi-asserted-by":"publisher","first-page":"8023","DOI":"10.1074\/jbc.M900301200","volume":"284","author":"CC Thoreen","year":"2009","unstructured":"Thoreen CC, Kang SA, Chang JW, Liu Q, Zhang J, Gao Y et al. (2009). An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem 284: 8023\u20138032.","journal-title":"J Biol Chem"},{"key":"BFonc2010393_CR45","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"M van Slegtenhorst","year":"1997","unstructured":"van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S et al. (1997). Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277: 805\u2013808.","journal-title":"Science"},{"key":"BFonc2010393_CR46","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1007\/s00018-008-8296-7","volume":"65","author":"J Vervoorts","year":"2008","unstructured":"Vervoorts J, Luscher B . (2008). Post-translational regulation of the tumor suppressor p27(KIP1). Cell Mol Life Sci 65: 3255\u20133264.","journal-title":"Cell Mol Life Sci"},{"key":"BFonc2010393_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2741\/3229","volume":"14","author":"B Viollet","year":"2009","unstructured":"Viollet B, Athea Y, Mounier R, Guigas B, Zarrinpashneh E, Horman S et al. (2009). AMPK: lessons from transgenic and knockout animals. Front Biosci 14: 19\u201344.","journal-title":"Front Biosci"},{"key":"BFonc2010393_CR48","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-05-3304","volume":"66","author":"FY Wu","year":"2006","unstructured":"Wu FY, Wang SE, Sanders ME, Shin I, Rojo F, Baselga J et al. (2006). Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity. Cancer Res 66: 2162\u20132172.","journal-title":"Cancer Res"},{"key":"BFonc2010393_CR49","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1073\/pnas.0810790106","volume":"106","author":"JJ Yu","year":"2009","unstructured":"Yu JJ, Robb VA, Morrison TA, Ariazi EA, Karbowniczek M, Astrinidis A et al. (2009). Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells. Proc Natl Acad Sci USA 106: 2635\u20132640.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2010393_CR50","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cmet.2009.03.012","volume":"9","author":"BB Zhang","year":"2009","unstructured":"Zhang BB, Zhou G, Li C . (2009). AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab 9: 407\u2013416.","journal-title":"Cell Metab"},{"key":"BFonc2010393_CR51","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1172\/JCI200317222","volume":"112","author":"H Zhang","year":"2003","unstructured":"Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, Bajraszewski N et al. (2003a). Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 112: 1223\u20131233.","journal-title":"J Clin Invest"},{"key":"BFonc2010393_CR52","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/ncb999","volume":"5","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, Gao X, Saucedo LJ, Ru B, Edgar BA, Pan D . (2003b). Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat Cell Biol 5: 578\u2013581.","journal-title":"Nat Cell Biol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2010393.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2010393","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2010393.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T13:38:29Z","timestamp":1647869909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2010393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,6]]},"references-count":52,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2010,12,16]]}},"alternative-id":["BFonc2010393"],"URL":"https:\/\/doi.org\/10.1038\/onc.2010.393","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13272058.14628167","asserted-by":"object"}]},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,6]]},"assertion":[{"value":"31 August 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}